A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression.

There is an urgent and unmet need for accurate biomarkers in Amyotrophic Lateral Sclerosis. A pharmaco-metabolomics study was conducted using plasma samples from the TRO19622 (olesoxime) trial to assess the link between early metabolomic profiles and clinical outcomes. Patients included in this tria...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hélène Blasco, Franck Patin, Amandine Descat, Guillaume Garçon, Philippe Corcia, Patrick Gelé, Timothée Lenglet, Peter Bede, Vincent Meininger, David Devos, Jean François Gossens, Pierre-François Pradat
Format:	Artigo
Jezik:	Inglês
Izdano:	Public Library of Science (PLoS) 2018-01-01
Serija:	PLoS ONE
Online dostop:	https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0198116/1/pone.0198116.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210223%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210223T052556Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=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
Oznake:	Označite Brez oznak, prvi označite!